|
Delayed
Nasdaq
01:06:56 2026-11-16 pm EST
|
5-day change | 1st Jan Change | ||
| 9.305 USD | -0.91% |
|
+2.37% | +39.13% |
| Nov. 10 | Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Nov. 10 | Harvard Bioscience, Inc., Q3 2026 Earnings Call, Nov 10, 2026 |
| Market Cap | 42.94M 38.91M 35.99M 32.47M 61.2M 4.05B 63.36M 434M 172M 2.16B 161M 158M 6.87B | P/E 2026 * |
-4.31x | P/E 2027 * | -16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 42.94M 38.91M 35.99M 32.47M 61.2M 4.05B 63.36M 434M 172M 2.16B 161M 158M 6.87B | EV / Sales 2026 * |
0.48x | EV / Sales 2027 * | 0.45x |
| Free-Float |
90.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| HBIO | Delayed | |
| HBIO | Real-time |
Last Transcript: Harvard Bioscience, Inc.
| 1 day | -0.37% | ||
| 1 week | +2.42% | ||
| Current month | +4.61% | ||
| 1 month | +15.08% | ||
| 3 months | +43.23% | ||
| 6 months | +86.20% | ||
| Current year | +39.20% |
| 1 week | 8.21 | 10.2 | |
| 1 month | 7.9 | 10.2 | |
| Current year | 4 | 10.2 | |
| 1 year | 4 | 10.2 | |
| 3 years | 2.81 | 55.6 | |
| 5 years | 2.81 | 78.4 | |
| 10 years | 2.81 | 87.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Duke
CEO | Chief Executive Officer | 55 | 2025-07-27 |
Mark Frost
DFI | Director of Finance/CFO | 63 | 2025-05-11 |
Diane Houston
CTO | Chief Tech/Sci/R&D Officer | - | 2019-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Katherine Eade
BRD | Director/Board Member | 52 | 2017-10-23 |
John Duke
BRD | Director/Board Member | 55 | 2025-06-01 |
Robert Gagnon
BRD | Director/Board Member | 52 | 2025-07-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/20/26 | Free | Chief Executive Officer | 75,000 | 0.1677% | ||
| 3/20/26 | Free | Chief Financial Officer | 30,000 | 0.0671% | ||
| 3/17/26 | Buy | Director | 10,000 | 0.0224% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.85% | +2.42% | +38.98% | -78.15% | 42.75M | ||
| -0.39% | -3.54% | +22.74% | +47.34% | 259B | ||
| -0.25% | -1.39% | +5.17% | +10.87% | 164B | ||
| -0.43% | -4.24% | -19.33% | +45.11% | 154B | ||
| -0.61% | -0.22% | -56.83% | -19.65% | 64.27B | ||
| -0.24% | +2.13% | +26.20% | +58.50% | 61.61B | ||
| +0.11% | +1.95% | +5.31% | -10.99% | 53.94B | ||
| -0.58% | -4.08% | +19.58% | +51.34% | 49.04B | ||
| +0.11% | -1.29% | +9.18% | +72.50% | 48.82B | ||
| -0.81% | -4.34% | +20.64% | +71.30% | 45.24B | ||
| Average | -0.38% | +1.87% | +7.16% | +24.82% | 90B | |
| Weighted average by Cap. | -0.38% | +0.57% | +4.85% | +35.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 90.09M 81.64M 75.51M 68.13M 128M 8.49B 133M 910M 360M 4.54B 338M 331M 14.4B | 94.8M 85.91M 79.46M 71.69M 135M 8.94B 140M 957M 379M 4.78B 356M 348M 15.16B |
| Net income | -9.92M -8.98M -8.31M -7.5M -14.13M -935M -14.63M -100M -39.66M -500M -37.2M -36.42M -1.59B | -2.77M -2.51M -2.32M -2.09M -3.94M -261M -4.08M -27.93M -11.06M -139M -10.38M -10.16M -442M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-16 | $9.305 | -0.91% | 11,015 |
| 26-11-13 | $9.390 | +1.90% | 18,784 |
| 26-11-12 | $9.215 | -4.80% | 15,568 |
| 26-11-11 | $9.680 | +4.54% | 105,422 |
| 26-11-10 | $9.260 | +1.87% | 88,184 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HBIO Stock
Select your edition
All financial news and data tailored to specific country editions
















